agreed a product approval is some time away, but I like this line in the Ann-
’Botanix also continues to assess complementary opportunities and partnerships for dermatology and antimicrobials products that can be rapidly brought to market which leverage the Company’s broad management experience capability and experience.’
i may be reading into this too much, but does the word ‘assess’ when talking about partnerships mean they have opportunities on the table? If not, wouldn’t they use the term ‘look for’ or ‘pursue’ rather than assess? Just a thought, IMO there may be a partnership announcement in the not too distant future. Dyor
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1702 Rosacea Study Approval
Ann: BTX 1702 Rosacea Study Approval, page-32
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $617.9M |
Open | High | Low | Value | Volume |
32.5¢ | 34.3¢ | 32.5¢ | $1.814M | 5.424M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 489055 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 340303 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 456250 | 0.335 |
1 | 15044 | 0.330 |
6 | 488242 | 0.325 |
13 | 722149 | 0.320 |
10 | 469099 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 310000 | 3 |
0.350 | 303272 | 7 |
0.355 | 264833 | 2 |
0.360 | 157708 | 4 |
0.365 | 259695 | 6 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online